PPARs: Protectors or Opponents of Myocardial Function? - Wikidata - wikimedia - TriplyDB

PPARs: Protectors or Opponents of Myocardial Function?

PPARs: Protectors or Opponents of Myocardial Function?

http://www.wikidata.org/entity/Q26771753

about

Fatty old hearts: role of cardiac lipotoxicity in age-related cardiomyopathy Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARα.A Systems Biology Approach to Investigating Sex Differences in Cardiac Hypertrophy.Sex Differences in Metabolic Cardiomyopathy.A novel physiological role for cardiac myoglobin in lipid metabolism.Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats.Beneficial effects of rosiglitazone and losartan combination in diabetic rats.Quercetin Prevents Diastolic Dysfunction Induced by a High-Cholesterol Diet: Role of Oxidative Stress and Bioenergetics in Hyperglycemic Rats.Krüppel-like factors: Crippling and un-crippling metabolic pathways.

P2860

Q26739009-1258B9DF-7262-4D5B-A852-76A640CF1C00 Q37054050-3FE42D1C-DCED-468F-B098-71314E5C10CE Q38597918-CE15BFC2-F19A-4917-B331-62509B4C24FA Q39118050-4D9E5551-E35C-46CD-AD5F-5CB9A648701E Q42320282-F5C05436-38E4-45BA-8E50-27C834A6132F Q46294693-E2EC65D5-5A5E-45E6-8868-93691E1F7155 Q50154239-794B1F44-69C0-4E89-9094-64D9210E0385 Q51735017-62F9140B-93F6-4BF7-B972-50ED3FE79F3E Q55079168-72013034-F76F-4A10-A620-E40306683DBB

P2860

PPARs: Protectors or Opponents of Myocardial Function?

http://www.wikidata.org/entity/Q26771753

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

PPARs: Protectors or Opponents of Myocardial Function?

@ast

PPARs: Protectors or Opponents of Myocardial Function?

@en

PPARs: Protectors or Opponents of Myocardial Function?

@nl

type

label

PPARs: Protectors or Opponents of Myocardial Function?

@ast

PPARs: Protectors or Opponents of Myocardial Function?

@en

PPARs: Protectors or Opponents of Myocardial Function?

@nl

prefLabel

PPARs: Protectors or Opponents of Myocardial Function?

@ast

PPARs: Protectors or Opponents of Myocardial Function?

@en

PPARs: Protectors or Opponents of Myocardial Function?

@nl

P1433

Q26771753-057A8AD0-8E36-4E27-8521-60D86A2B98F4

P1476

Q26771753-43C678F2-C548-4DFF-9DFC-8A5DB5B89727

P2093

Q26771753-55051282-9AF2-4633-97B2-5C96B2924CDE

Q26771753-FFE54A4F-48B7-463B-9501-575622781494

P2860

Q26771753-014EC3F9-6B4F-493D-97D2-E991ADE19F2E

Q26771753-02E80850-DABF-4FB1-A75C-338C95C82243

Q26771753-03A219B3-2880-4CB7-9A33-767311018D97

Q26771753-03B8497C-DFA5-4CD5-B070-CE2F44EDC16B

Q26771753-03D0BB17-B8C4-49E9-9C95-6F63CF81F2B1

Q26771753-04312225-D272-4500-9888-9D38DE8FBF2B

Q26771753-049B01BD-7CE3-47FE-8725-43AF5502D764

Q26771753-04C2C282-C3EC-4D8C-A231-9F51E2AE4522

Q26771753-067DE125-DE5A-4751-B904-AE66CB0FABA8

Q26771753-072FE5FB-DA30-4EBC-8BCF-81841563188D

P304

Q26771753-2F231F2A-20A1-4B36-BCCE-72FE35133051

P31

Q26771753-8434D718-A2B2-4DAA-BED8-58B349830F29

P3181

Q26771753-120CCAD0-666D-452A-B3EB-77D1AC647B5D

P356

Q26771753-ABC45AC4-E70F-462B-AAEB-2C35D50F7446

P407

Q26771753-7D56F35A-3473-4268-B26E-C25FBEAC5162

P478

Q26771753-9B078647-FE1B-42A4-B23D-993F159E0C29

P50

Q26771753-F6B58AAD-F322-45CC-9468-2D81CF29984C

P577

Q26771753-5D900CE5-1681-4699-A595-C50F3B55EAFC

P5875

Q26771753-9398E9E7-4A90-4873-AC0F-141B948728B7

P698

Q26771753-2BA772DF-619C-417E-8A39-CE26F9A80EC6

P921

Q26771753-C72EEA71-6A26-43C7-B9D0-B9659B4D6D28

P932

Q26771753-5EA81F13-D93E-460A-BDAE-4FDC9CED1E8F

P3181

P356

P1433

P1476

PPARs: Protectors or Opponents of Myocardial Function?

@en

P2093

Christine J Pol

http://www.w3.org/2001/XMLSchema#string

Melissa Lieu

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta

Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance

SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR

The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle

AMPK and PPARdelta agonists are exercise mimetics

P304

835985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

748480

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2015/835985

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Konstantinos Drosatos

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285656878

http://www.w3.org/2001/XMLSchema#string

P698

26713088

http://www.w3.org/2001/XMLSchema#string

P921

P932

4680114

http://www.w3.org/2001/XMLSchema#string